HK Stock MarketDetailed Quotes

REGAL PARTNERS (01575)

Watchlist
  • 0.051
  • +0.001+2.00%
Market Closed Apr 24 09:30 CST
196.86MMarket Cap-2.04P/E (TTM)

REGAL PARTNERS (01575) Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
Cash flow from operating activities
Earning before tax
----
-239.24%-88.64M
----
87.15%-26.13M
----
-69.11%-203.42M
----
-36.94%-120.29M
----
50.91%-87.84M
Profit adjustment
Interest (income) - adjustment
----
65.08%-22K
----
52.63%-63K
----
74.86%-133K
----
52.21%-529K
----
18.42%-1.11M
Investment loss (gain)
----
----
----
----
----
----
----
-74.92%78K
----
--311K
Impairment and provisions:
----
182.96%8.49M
----
-136.62%-10.23M
----
225.62%27.93M
----
-135.10%-22.24M
----
51.56%63.35M
-Impairment of property, plant and equipment (reversal)
----
--56K
----
----
----
----
----
-62.59%4.85M
----
452.17%12.95M
-Impairmen of inventory (reversal)
----
101.78%491K
----
-237.26%-27.62M
----
152.41%20.12M
----
-196.36%-38.4M
----
220.04%39.85M
-Impairment of trade receivables (reversal)
----
-92.75%1.19M
----
123.83%16.45M
----
60.25%7.35M
----
142.43%4.59M
----
-169.39%-10.81M
-Other impairments and provisions
----
615.48%6.75M
----
104.56%943K
----
-93.15%461K
----
-68.49%6.73M
----
86.94%21.35M
Revaluation surplus:
----
-83.63%1.54M
----
3,110.58%9.41M
----
--293K
----
----
----
-82.91%-14.24M
-Derivative financial instruments fair value (increase)
----
75.08%-76K
----
-204.10%-305K
----
--293K
----
----
----
----
-Other fair value changes
----
-83.36%1.62M
----
--9.71M
----
----
----
----
----
-170.93%-14.24M
Asset sale loss (gain):
----
-50.42%237K
----
122.42%478K
----
69.90%-2.13M
----
80.85%-7.08M
----
-246,553.33%-37M
-Loss (gain) from sale of subsidiary company
----
----
----
----
----
----
----
85.72%-8.25M
----
---57.76M
-Loss (gain) on sale of property, machinery and equipment
----
-50.42%237K
----
122.42%478K
----
-282.85%-2.13M
----
-92.56%1.17M
----
104,613.33%15.68M
-Loss (gain) from selling other assets
----
----
----
----
----
----
----
----
----
--5.09M
Depreciation and amortization:
----
-21.22%23.66M
----
110.12%30.04M
----
22.05%14.3M
----
-70.63%11.71M
----
-33.31%39.88M
Financial expense
----
42.19%19.89M
----
86.50%13.99M
----
-66.61%7.5M
----
27.73%22.47M
----
-40.03%17.59M
Special items
----
109.27%6.79M
----
-6,449.70%-73.21M
----
151.75%1.15M
----
104.01%458K
----
-238.68%-11.43M
Operating profit before the change of operating capital
----
49.64%-28.06M
----
63.93%-55.72M
----
-33.87%-154.51M
----
-278.60%-115.42M
----
37.70%-30.49M
Change of operating capital
Inventory (increase) decrease
----
-71.77%7.39M
----
-31.25%26.19M
----
-69.68%38.1M
----
390.66%125.66M
----
-218.65%-43.23M
Accounts receivable (increase)decrease
----
-1,493.51%-1.07M
----
-95.16%77K
----
-98.29%1.59M
----
16.39%93.09M
----
-80.25%79.98M
Accounts payable increase (decrease)
----
14.17%-12.94M
----
-200.13%-15.08M
----
116.45%15.06M
----
26.90%-91.56M
----
-32.55%-125.25M
prepayments (increase)decrease
----
-97.30%904K
----
184.63%33.48M
----
-156.16%-39.56M
----
-23.46%70.45M
----
161.54%92.04M
Special items for working capital changes
----
-9.76%-4.97M
----
-103.46%-4.53M
----
63.22%-2.23M
----
-58.60%-6.05M
----
-332.56%-3.81M
Cash  from business operations
----
-148.70%-38.75M
----
88.99%-15.58M
----
-285.82%-141.55M
----
347.65%76.18M
----
-120.49%-30.76M
Other taxs
----
----
----
--68K
----
----
----
104.64%730K
----
8.38%-15.74M
Special items of business
129.56%6.02M
----
41.59%-20.37M
----
-239.13%-34.88M
----
94.19%-10.28M
----
-310.76%-177.15M
----
Net cash from operations
129.56%6.02M
-149.79%-38.75M
41.59%-20.37M
89.04%-15.51M
-239.13%-34.88M
-284.06%-141.55M
94.19%-10.28M
265.40%76.91M
-310.76%-177.15M
-134.98%-46.5M
Cash flow from investment activities
Interest received - investment
50.00%6K
-65.08%22K
-92.45%4K
-52.63%63K
76.67%53K
-74.86%133K
-90.74%30K
-52.21%529K
-52.00%324K
-18.42%1.11M
Loan receivable (increase) decrease
----
109.06%60K
-99.24%55K
-119.84%-662K
147.81%7.28M
105.24%3.34M
---15.23M
---63.64M
----
----
Decrease in deposits (increase)
----
----
----
-99.92%12K
----
-73.58%14.67M
-35.57%14.67M
-8.90%55.53M
-27.67%22.76M
259.21%60.96M
Sale of fixed assets
--106K
-13.03%407K
----
-80.04%468K
--168K
711.42%2.35M
----
-99.60%289K
----
267,222.22%72.18M
Purchase of fixed assets
-833.06%-1.13M
79.07%-836K
93.51%-121K
68.28%-3.99M
62.98%-1.87M
-400.80%-12.59M
-174.40%-5.04M
96.31%-2.51M
97.12%-1.84M
-141.67%-68.04M
Sale of subsidiaries
----
----
----
----
----
----
----
-91.53%8.71M
--34.84M
--102.83M
Cash on investment
----
----
----
---11.15M
---11.13M
----
----
----
----
----
Other items in the investment business
----
----
----
----
----
----
----
----
----
847.42%16.96M
Net cash from investment operations
-1,540.32%-1.02M
97.73%-347K
98.87%-62K
-293.28%-15.26M
1.37%-5.49M
816.52%7.9M
-109.93%-5.57M
-100.59%-1.1M
-4.68%56.09M
296.42%185.99M
Net cash before financing
124.49%5M
-27.04%-39.09M
49.38%-20.43M
76.98%-30.77M
-154.67%-40.37M
-276.32%-133.66M
86.91%-15.85M
-45.66%75.8M
-184.72%-121.06M
264.82%139.49M
Cash flow from financing activities
New borrowing
-93.72%4.35M
-13.37%134.44M
-38.77%69.32M
68.59%155.18M
138.03%113.21M
-51.34%92.05M
-89.30%47.56M
-73.03%189.18M
91.78%444.66M
45.00%701.58M
Refund
14.48%-23.83M
40.68%-59.03M
53.37%-27.87M
-48.44%-99.51M
-73.56%-59.76M
73.02%-67.04M
88.00%-34.43M
69.97%-248.44M
16.48%-286.96M
-68.73%-827.34M
Issuing shares
--25.79M
----
----
----
----
--119.33M
--19.6M
----
----
----
Interest paid - financing
56.24%-2.29M
-128.61%-13.46M
-201.90%-5.24M
-211.81%-5.89M
-32.14%-1.74M
89.39%-1.89M
86.29%-1.31M
-99.80%-17.8M
-54.59%-9.58M
-13.16%-8.91M
Issuance expenses and redemption of securities expenses
---110K
----
----
----
----
---1.35M
---236K
----
----
----
Other items of the financing business
--6K
----
----
----
----
----
----
----
----
----
Net cash from financing operations
-116.65%-3.94M
101.89%38.4M
-35.14%23.65M
-84.51%19.02M
59.79%36.47M
227.04%122.79M
-83.59%22.82M
44.22%-96.66M
195.28%139.09M
-107.40%-173.28M
Effect of rate
40.82%-287K
-100.66%-59K
-176.98%-485K
79.40%8.92M
-92.32%630K
405.10%4.97M
2,984.96%8.21M
-26.67%-1.63M
111.52%266K
83.01%-1.29M
Net Cash
-66.88%1.07M
94.09%-695K
182.60%3.22M
-8.17%-11.75M
-155.89%-3.9M
47.90%-10.87M
-61.31%6.97M
38.28%-20.86M
685.61%18.03M
25.43%-33.79M
Begining period cash
-15.86%4M
-37.38%4.75M
-37.38%4.75M
-43.72%7.59M
-43.72%7.59M
-62.51%13.49M
-62.51%13.49M
-49.37%35.97M
-49.37%35.97M
-42.67%71.05M
Cash at the end
-36.18%4.78M
-15.86%4M
73.19%7.49M
-37.38%4.75M
-84.92%4.32M
-43.72%7.59M
-47.17%28.66M
-62.51%13.49M
-17.36%54.26M
-49.37%35.97M
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified Opinion
Auditor
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020
Cash flow from operating activities
Earning before tax -----239.24%-88.64M----87.15%-26.13M-----69.11%-203.42M-----36.94%-120.29M----50.91%-87.84M
Profit adjustment
Interest (income) - adjustment ----65.08%-22K----52.63%-63K----74.86%-133K----52.21%-529K----18.42%-1.11M
Investment loss (gain) -----------------------------74.92%78K------311K
Impairment and provisions: ----182.96%8.49M-----136.62%-10.23M----225.62%27.93M-----135.10%-22.24M----51.56%63.35M
-Impairment of property, plant and equipment (reversal) ------56K---------------------62.59%4.85M----452.17%12.95M
-Impairmen of inventory (reversal) ----101.78%491K-----237.26%-27.62M----152.41%20.12M-----196.36%-38.4M----220.04%39.85M
-Impairment of trade receivables (reversal) -----92.75%1.19M----123.83%16.45M----60.25%7.35M----142.43%4.59M-----169.39%-10.81M
-Other impairments and provisions ----615.48%6.75M----104.56%943K-----93.15%461K-----68.49%6.73M----86.94%21.35M
Revaluation surplus: -----83.63%1.54M----3,110.58%9.41M------293K-------------82.91%-14.24M
-Derivative financial instruments fair value (increase) ----75.08%-76K-----204.10%-305K------293K----------------
-Other fair value changes -----83.36%1.62M------9.71M---------------------170.93%-14.24M
Asset sale loss (gain): -----50.42%237K----122.42%478K----69.90%-2.13M----80.85%-7.08M-----246,553.33%-37M
-Loss (gain) from sale of subsidiary company ----------------------------85.72%-8.25M-------57.76M
-Loss (gain) on sale of property, machinery and equipment -----50.42%237K----122.42%478K-----282.85%-2.13M-----92.56%1.17M----104,613.33%15.68M
-Loss (gain) from selling other assets --------------------------------------5.09M
Depreciation and amortization: -----21.22%23.66M----110.12%30.04M----22.05%14.3M-----70.63%11.71M-----33.31%39.88M
Financial expense ----42.19%19.89M----86.50%13.99M-----66.61%7.5M----27.73%22.47M-----40.03%17.59M
Special items ----109.27%6.79M-----6,449.70%-73.21M----151.75%1.15M----104.01%458K-----238.68%-11.43M
Operating profit before the change of operating capital ----49.64%-28.06M----63.93%-55.72M-----33.87%-154.51M-----278.60%-115.42M----37.70%-30.49M
Change of operating capital
Inventory (increase) decrease -----71.77%7.39M-----31.25%26.19M-----69.68%38.1M----390.66%125.66M-----218.65%-43.23M
Accounts receivable (increase)decrease -----1,493.51%-1.07M-----95.16%77K-----98.29%1.59M----16.39%93.09M-----80.25%79.98M
Accounts payable increase (decrease) ----14.17%-12.94M-----200.13%-15.08M----116.45%15.06M----26.90%-91.56M-----32.55%-125.25M
prepayments (increase)decrease -----97.30%904K----184.63%33.48M-----156.16%-39.56M-----23.46%70.45M----161.54%92.04M
Special items for working capital changes -----9.76%-4.97M-----103.46%-4.53M----63.22%-2.23M-----58.60%-6.05M-----332.56%-3.81M
Cash  from business operations -----148.70%-38.75M----88.99%-15.58M-----285.82%-141.55M----347.65%76.18M-----120.49%-30.76M
Other taxs --------------68K------------104.64%730K----8.38%-15.74M
Special items of business 129.56%6.02M----41.59%-20.37M-----239.13%-34.88M----94.19%-10.28M-----310.76%-177.15M----
Net cash from operations 129.56%6.02M-149.79%-38.75M41.59%-20.37M89.04%-15.51M-239.13%-34.88M-284.06%-141.55M94.19%-10.28M265.40%76.91M-310.76%-177.15M-134.98%-46.5M
Cash flow from investment activities
Interest received - investment 50.00%6K-65.08%22K-92.45%4K-52.63%63K76.67%53K-74.86%133K-90.74%30K-52.21%529K-52.00%324K-18.42%1.11M
Loan receivable (increase) decrease ----109.06%60K-99.24%55K-119.84%-662K147.81%7.28M105.24%3.34M---15.23M---63.64M--------
Decrease in deposits (increase) -------------99.92%12K-----73.58%14.67M-35.57%14.67M-8.90%55.53M-27.67%22.76M259.21%60.96M
Sale of fixed assets --106K-13.03%407K-----80.04%468K--168K711.42%2.35M-----99.60%289K----267,222.22%72.18M
Purchase of fixed assets -833.06%-1.13M79.07%-836K93.51%-121K68.28%-3.99M62.98%-1.87M-400.80%-12.59M-174.40%-5.04M96.31%-2.51M97.12%-1.84M-141.67%-68.04M
Sale of subsidiaries -----------------------------91.53%8.71M--34.84M--102.83M
Cash on investment ---------------11.15M---11.13M--------------------
Other items in the investment business ------------------------------------847.42%16.96M
Net cash from investment operations -1,540.32%-1.02M97.73%-347K98.87%-62K-293.28%-15.26M1.37%-5.49M816.52%7.9M-109.93%-5.57M-100.59%-1.1M-4.68%56.09M296.42%185.99M
Net cash before financing 124.49%5M-27.04%-39.09M49.38%-20.43M76.98%-30.77M-154.67%-40.37M-276.32%-133.66M86.91%-15.85M-45.66%75.8M-184.72%-121.06M264.82%139.49M
Cash flow from financing activities
New borrowing -93.72%4.35M-13.37%134.44M-38.77%69.32M68.59%155.18M138.03%113.21M-51.34%92.05M-89.30%47.56M-73.03%189.18M91.78%444.66M45.00%701.58M
Refund 14.48%-23.83M40.68%-59.03M53.37%-27.87M-48.44%-99.51M-73.56%-59.76M73.02%-67.04M88.00%-34.43M69.97%-248.44M16.48%-286.96M-68.73%-827.34M
Issuing shares --25.79M------------------119.33M--19.6M------------
Interest paid - financing 56.24%-2.29M-128.61%-13.46M-201.90%-5.24M-211.81%-5.89M-32.14%-1.74M89.39%-1.89M86.29%-1.31M-99.80%-17.8M-54.59%-9.58M-13.16%-8.91M
Issuance expenses and redemption of securities expenses ---110K-------------------1.35M---236K------------
Other items of the financing business --6K------------------------------------
Net cash from financing operations -116.65%-3.94M101.89%38.4M-35.14%23.65M-84.51%19.02M59.79%36.47M227.04%122.79M-83.59%22.82M44.22%-96.66M195.28%139.09M-107.40%-173.28M
Effect of rate 40.82%-287K-100.66%-59K-176.98%-485K79.40%8.92M-92.32%630K405.10%4.97M2,984.96%8.21M-26.67%-1.63M111.52%266K83.01%-1.29M
Net Cash -66.88%1.07M94.09%-695K182.60%3.22M-8.17%-11.75M-155.89%-3.9M47.90%-10.87M-61.31%6.97M38.28%-20.86M685.61%18.03M25.43%-33.79M
Begining period cash -15.86%4M-37.38%4.75M-37.38%4.75M-43.72%7.59M-43.72%7.59M-62.51%13.49M-62.51%13.49M-49.37%35.97M-49.37%35.97M-42.67%71.05M
Cash at the end -36.18%4.78M-15.86%4M73.19%7.49M-37.38%4.75M-84.92%4.32M-43.72%7.59M-47.17%28.66M-62.51%13.49M-17.36%54.26M-49.37%35.97M
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ------------------Unqualified Opinion
Auditor --National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More